Antisense Tcf inhibits the neoplastic growth of liver cancer cells

Journal of Cancer Research and Clinical Oncology
Ying JiangXin Wu

Abstract

T cell transcription factors are nuclear effectors of the Wnt signaling transduction pathway and play crucial roles in embryonic and malignant development. Our previous study showed increased expression level of Tcf mRNA in liver cancer. In the present paper, antisense Tcf RNA was used to explore the possible therapeutic effect on liver cancer cells by interrupting the abnormal Wnt pathway. Antisense expression vectors containing the conserved sequence of Tcf cDNA were constructed and transfected into a human liver cancer cell line SMMC-7721. Tumorigenic potential was determined by cellular growth assay and tumor growth in nude mice. The stable transfection of anti-sense Tcf in SMMC-7721 cells significantly reduced Tcf expression at both mRNA and protein levels compared with parental and mock-transfected cells. Antisense-mediated suppression of Tcf inhibited the in vitro proliferation and in vivo tumor formation ability. Furthermore, the apoptosis rate of antisense transfected cells was significantly higher than that of control, indicating that antisense RNA suppressed malignant growth by induction of apoptosis. Our studies demonstrate the critical role of Wnt signaling pathway in the neoplastic growth of liver cancer cells and...Continue Reading

References

Oct 1, 1985·Analytical Biochemistry·P K SmithD C Klenk
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·P J MorinK W Kinzler
Feb 7, 1998·Genes & Development·K M Cadigan, R Nusse
May 21, 1998·Antisense & Nucleic Acid Drug Development·C A Stein
Sep 4, 1998·Science·T C HeK W Kinzler
Jan 23, 1999·The American Journal of Pathology·N BarkerH Clevers
Oct 21, 1999·Biochimica Et Biophysica Acta·J Roose, H Clevers
Dec 2, 1999·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·P J Morin
Dec 10, 1999·Experimental Cell Research·E T Strovel, D J Sussman
Feb 26, 2000·Trends in Pharmacological Sciences·M LindgrenU Langel
May 12, 2000·Biochimica Et Biophysica Acta·S T Crooke
Jul 18, 2000·Journal of the American College of Surgeons·D W GreenJ A Drebin
Jun 8, 2001·Cell·P Polakis
Jun 12, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C M RudinE E Vokes
Jun 19, 2003·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Miltiadis MatsagasDimitri P Mikhailidis

❮ Previous
Next ❯

Citations

Oct 13, 2006·World Journal of Gastroenterology : WJG·Ruben Hernandez-AlcocebaJesus Prieto
May 6, 2020·Drug Design, Development and Therapy·Xiao-Xia YuYin-Lin Ge

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis